このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management (remote monitor)

2026年11月17日 更新者:doaa mansour ali、Cairo University

Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management Among Patients With Diabetes Mellitus

Diabetes mellitus is a chronic condition that often imposes significant psychological distress and requires complex daily self-management. This randomized controlled trial aims to evaluate the effectiveness of a structured nurse-led intervention combined with patient navigation on reducing psychological distress and improving self-management behaviors among patients with diabetes. Eligible adult patients with diabetes will be randomly assigned into either an intervention group receiving the nurse-led educational, psychosocial, and navigation support program alongside routine care, or a control group receiving routine diabetes care alone. Outcomes related to diabetes-related psychological distress and self-care adherence will be assessed at baseline and following the intervention period to determine the clinical impact of the program.

調査の概要

状態

募集

条件

介入・治療

詳細な説明

Background and Rationale:

Living with diabetes requires continuous lifestyle modifications, medication adherence, and blood glucose monitoring, which frequently lead to diabetes-related psychological distress, anxiety, and burnout. High levels of psychological distress negatively affect treatment adherence and glycemic control. Nurse-led interventions coupled with patient navigation offer a holistic, patient-centered approach by providing tailored health education, emotional support, problem-solving skills, and assistance in overcoming healthcare system barriers.

Study Objective:

The primary objective of this study is to examine the effect of a nurse-led intervention and patient navigation program on psychological distress and diabetes self-management among patients with diabetes.

Study Design and Methodology:

This study utilizes a two-arm, parallel-group randomized controlled trial (RCT) design. After obtaining informed consent and completing baseline assessments, eligible participants will be randomly allocated in a 1:1 ratio into two equal groups:

  1. Intervention Group: Participants will receive a structured nurse-led intervention and patient navigation program in addition to standard care. The intervention encompasses individualized diabetes self-management education, psychological and coping support, goal setting, care coordination, and regular follow-up reminders to facilitate access to healthcare services and address barriers to care.
  2. Control Group: Participants will continue to receive their standard routine diabetes care without the additional navigation or nurse-led sessions.

Outcome Assessment:

Both groups will be evaluated at baseline (pre-test) and after completion of the intervention (post-test) using validated psychometric and behavioral instruments measuring diabetes-related psychological distress (such as the Diabetes Distress Scale) and diabetes self-management practices (such as the Summary of Diabetes Self-Care Activities). Data will be statistically analyzed to compare pre- and post-intervention changes within and between the two study groups.

研究の種類

介入

入学 (推定)

80

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Doaa mansour Ali, assisstant professor
  • 電話番号:01116240970
  • メール:dodo8836@yahoo.com

研究場所

      • Cairo、エジプト
        • 募集
        • The study will be conducted at the Diabetes and Endocrinology Outpatient Clinics of Helwan General Hospital, a major secondary-level governmental healthcare facility operating under the Ministry of Health and Population in Cairo, Egypt.
        • コンタクト:
          • Doaa mansour Ali, assisstant professor
          • 電話番号:01116240970
          • メール:dodo8836@yahoo.com

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

Participants will be included in the study if they meet the following criteria:

  1. Adults aged 18 years or older.
  2. Patients with a confirmed diagnosis of type 1 or type 2 diabetes mellitus.
  3. Patients receiving routine diabetes care at the selected study setting.
  4. Patients who have access to a telephone or another suitable remote communication method.
  5. Patients who are willing to participate in the study and provide written informed consent.
  6. Patients who are able to understand and complete the study questionnaires in the selected validated language.
  7. Patients who are expected to be available throughout the intervention and follow-up period

Exclusion Criteria:

  1. Patients experiencing an acute medical condition requiring emergency treatment or hospitalization at the time of recruitment.
  2. Patients with severe cognitive impairment or communication difficulties that prevent meaningful participation in the intervention and completion of the assessment tools.
  3. Patients experiencing an acute psychiatric crisis requiring immediate specialized mental health intervention.
  4. Patients enrolled in another intensive remote diabetes-management program that could substantially overlap with the proposed intervention.
  5. Patients who decline participation or withdraw their informed consent. Note: A previous diagnosis of depression or anxiety should not automatically be an exclusion criterion unless justified by the study protocol. Including patients with stable mental health conditions may improve the applicability of the findings concerning psychological distress among diabetic patients.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Nurse led intervention and patient navigation

Participants will receive a nurse-led remote monitoring and patient navigation intervention aimed at supporting their psychological well-being and managing psychological distress over the intervention period.

Nurse-led remote monitoring and patient navigation: refers to a structured, eight-week intervention delivered by a trained community health nurse through scheduled telephone calls or other agreed remote communication methods. It includes reviewing patients' reported health status, reinforcing diabetes self-management education, identifying barriers to healthcare access, facilitating appointments and referrals, and coordinating follow-up with healthcare providers.

介入なし:Usual care group

Participants will receive usual care without the nurse-led remote monitoring and patient navigation intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
changes in psychological distress
時間枠:3 months

Assessment of changes in psychological distress among participants using the specified psychological distress assessment scale, comparing baseline and post-intervention measurements.

3 months
Change in Diabetes Self-Management
時間枠:3 months

Assessment of changes in diabetes self-management among participants using the specified diabetes self-management assessment tool, comparing baseline and post-intervention measurements.

3 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Doaa MANSOUR Ali, ASSISSTANT PROFESSOR、Cairo University

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年10月12日

一次修了 (実際)

2026年10月12日

研究の完了 (推定)

2027年1月1日

試験登録日

最初に提出

2026年11月12日

QC基準を満たした最初の提出物

2026年11月17日

最初の投稿 (実際)

2026年11月19日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月19日

QC基準を満たした最後の更新が送信されました

2026年11月17日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • HUNURSERC2026/10/67/14

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data (IPD) collected during this study will not be shared with other researchers. The data will be used exclusively for the purposes of the current study and will be kept confidential to protect participants' privacy.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。